HIV Infection Indicator Disease-Based Active Case Finding in a University Hospital: Results from the SHOT Project
暂无分享,去创建一个
S. Babudieri | A. De Vito | C. Fozza | A. Fois | G. Madeddu | V. Fiore | F. Filigheddu | M. Montesu | C. Putzu | P. Bagella | M. S. Mameli | N. Manzoni | A. Colpani
[1] T. van der Poll,et al. Improving indicator-condition guided testing for HIV in the hospital setting (PROTEST 2·0): A multicenter, interrupted time-series analysis , 2022, The Lancet regional health. Europe.
[2] M. C. Meloni,et al. How Little Do We Know about HIV and STIs Prevention? Results from a Web-Based Survey among the General Population , 2022, Healthcare.
[3] Moira Walsh,et al. “It is not an acceptable disease”: A qualitative study of HIV-related stigma and discrimination and impacts on health and wellbeing for people from ethnically diverse backgrounds in Australia , 2021, BMC Public Health.
[4] A. Antinori,et al. Time spent with viral load≤200 copies/mL in a cohort of people with HIV seen for care in Italy during the U=U prevention campaign era. , 2021, AIDS.
[5] A. Amato-Gauci,et al. HIV testing strategies employed in health care settings in the European Union/European Economic Area (EU/EEA): evidence from a systematic review , 2019, HIV medicine.
[6] G. d’Ettorre,et al. Efficacy and safety of dolutegravir-based regimens in advanced HIV-infected naïve patients: Results from a multicenter cohort study. , 2019, Antiviral research.
[7] Hansjakob Furrer,et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study , 2019, The Lancet.
[8] M. Boffito,et al. Rapid initiation of antiretroviral therapy at HIV diagnosis: definition, process, knowledge gaps , 2019, HIV medicine.
[9] Felipe García,et al. Indicator condition-guided HIV testing with an electronic prompt in primary healthcare: a before and after evaluation of an intervention , 2019, Sexually Transmitted Infections.
[10] P. Narciso,et al. Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial , 2018, The Journal of antimicrobial chemotherapy.
[11] N. Ford,et al. Benefits and risks of rapid initiation of antiretroviral therapy , 2017, AIDS.
[12] Pietro Vernazza,et al. Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy. , 2016, JAMA.
[13] A. Grzeszczuk,et al. Auditing HIV Testing Rates across Europe: Results from the HIDES 2 Study , 2015, PloS one.
[14] H. Lane,et al. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. , 2015, The New England journal of medicine.
[15] D. Cooper,et al. The Opposites Attract Study of viral load, HIV treatment and HIV transmission in serodiscordant homosexual male couples: design and methods , 2014, BMC Public Health.
[16] C. Murrill,et al. Global epidemiology of HIV. , 2014, Infectious disease clinics of North America.
[17] Stefan Esser,et al. Feasibility and Effectiveness of Indicator Condition-Guided Testing for HIV: Results from HIDES I (HIV Indicator Diseases across Europe Study) , 2013, PloS one.
[18] C. Watkins-Hayes. Ending the AIDS epidemic , 2012 .
[19] Myron S. Cohen,et al. HIV treatment as prevention and HPTN 052. , 2012, Current opinion in HIV and AIDS.
[20] Christine A. Lee,et al. The natural history of HIV infection. , 1989, AIDS care.